Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous tolerogenic proinsulin peptide-loaded dendritic cells PIpepTolDC

A vaccine composed of autologous tolerogenic dendritic cells (DCs) loaded with the beta cell protein proinsulin peptide (PIpep), C19-A3, with potential immunosuppressive and immune-regulating activities. Upon intradermal administration, the autologous tolerogenic PIpep-loaded DCs may induce proinsulin-specific regulatory T cells (Tregs). This may suppress the autoimmune destruction of the insulin-producing beta cells, thereby protecting the beta cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous tolerogenic DC with proinsulin peptide PIpepTolDC
autologous tolerogenic PIpep-loaded dendritic cells PIpepTolDC
PIpepTolDC vaccine
proinsulin-loaded tolerogenic DCs PIpepTolDC
tolerogenic DC vaccine PIpepTolDC
Code name:PIpepTolDC
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search